Kristen Sgambat1, Jennifer Roem2, Mark Mitsnefes3, Anthony A Portale4, Susan Furth5, Bradley Warady6, Asha Moudgil7. 1. Department of Nephrology, Children's National Health System, 111 Michigan Avenue NW, Washington, DC, 20010, USA. ksgambat@childrensnational.org. 2. Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 3. Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. 4. University of California, San Francisco, CA, USA. 5. The Children's Hospital of Philadelphia, Department of Pediatrics, Philadelphia, PA, USA. 6. Children's Mercy Kansas City, Kansas City, MO, USA. 7. Department of Nephrology, Children's National Health System, 111 Michigan Avenue NW, Washington, DC, 20010, USA.
Abstract
BACKGROUND: Cardiovascular (CV) risk is high in children with chronic kidney disease (CKD), and further compounded in those who are overweight. Children with CKD have a unique body habitus not accurately assessed by body mass index (BMI). Waist-to-height ratio (WHr), a better predictor of CV risk in populations with short stature, has not been investigated in children with CKD. METHODS: Analysis of 1723 visits of 593 participants enrolled in the Chronic Kidney Disease in Children (CKiD) study was conducted. CKiD participants had BMI and WHr measured and classified as follows: (1) lean (WHr ≤ 0.49, BMI < 85th percentile); (2) WHr-overweight (WHr > 0.49, BMI < 85th percentile); (3) BMI-overweight (WHr ≤ 0.49, BMI ≥ 85th percentile); or (4) overweight by both BMI and WHr. Left ventricular mass index (LVMI), fasting lipids, fibroblast growth factor 23 (FGF23), blood pressure, and glucose were measured as markers of CV risk. Linear mixed-effects regression was used to evaluate differences in CV markers between overweight and lean groups. RESULTS: Participants were 12.2 years old, 60% male, and 17% African-American. Approximately 15% were overweight by WHr but not by BMI. Overweight status by WHr-only or both WHr and BMI was associated with lower high-density lipoprotein (HDL) and higher LVMI, triglycerides, and non-HDL cholesterol compared to lean. CV markers of participants overweight by BMI-only were similar to those of lean children. CONCLUSIONS: WHr-adiposity is associated with an adverse CV risk profile in children with CKD. A significant proportion of children with central adiposity are missed by BMI. WHr should be utilized as a screening tool for CV risk in this population.
BACKGROUND: Cardiovascular (CV) risk is high in children with chronic kidney disease (CKD), and further compounded in those who are overweight. Children with CKD have a unique body habitus not accurately assessed by body mass index (BMI). Waist-to-height ratio (WHr), a better predictor of CV risk in populations with short stature, has not been investigated in children with CKD. METHODS: Analysis of 1723 visits of 593 participants enrolled in the Chronic Kidney Disease in Children (CKiD) study was conducted. CKiDparticipants had BMI and WHr measured and classified as follows: (1) lean (WHr ≤ 0.49, BMI < 85th percentile); (2) WHr-overweight (WHr > 0.49, BMI < 85th percentile); (3) BMI-overweight (WHr ≤ 0.49, BMI ≥ 85th percentile); or (4) overweight by both BMI and WHr. Left ventricular mass index (LVMI), fasting lipids, fibroblast growth factor 23 (FGF23), blood pressure, and glucose were measured as markers of CV risk. Linear mixed-effects regression was used to evaluate differences in CV markers between overweight and lean groups. RESULTS:Participants were 12.2 years old, 60% male, and 17% African-American. Approximately 15% were overweight by WHr but not by BMI. Overweight status by WHr-only or both WHr and BMI was associated with lower high-density lipoprotein (HDL) and higher LVMI, triglycerides, and non-HDL cholesterol compared to lean. CV markers of participants overweight by BMI-only were similar to those of lean children. CONCLUSIONS: WHr-adiposity is associated with an adverse CV risk profile in children with CKD. A significant proportion of children with central adiposity are missed by BMI. WHr should be utilized as a screening tool for CV risk in this population.
Entities:
Keywords:
Body mass index; Dyslipidemia; Fibroblast growth factor 23; Hypertension; Left ventricular mass index; Obesity
Authors: Hiren P Patel; Jeffrey M Saland; Derek K Ng; Shuai Jiang; Bradley A Warady; Susan L Furth; Joseph T Flynn Journal: J Pediatr Date: 2017-12 Impact factor: 4.406
Authors: Mikko Kankaanpää; Hanna-Riikka Lehto; Jussi P Pärkkä; Markku Komu; Antti Viljanen; Ele Ferrannini; Juhani Knuuti; Pirjo Nuutila; Riitta Parkkola; Patricia Iozzo Journal: J Clin Endocrinol Metab Date: 2006-08-22 Impact factor: 5.958
Authors: Susan L Furth; Stephen R Cole; Marva Moxey-Mims; Frederick Kaskel; Robert Mak; George Schwartz; Craig Wong; Alvaro Muñoz; Bradley A Warady Journal: Clin J Am Soc Nephrol Date: 2006-07-19 Impact factor: 8.237
Authors: Tammy M Brady; Jennifer Roem; Christopher Cox; Michael F Schneider; Amy C Wilson; Susan L Furth; Bradley A Warady; Mark Mitsnefes Journal: Am J Kidney Dis Date: 2020-05-07 Impact factor: 8.860
Authors: Shiwen Yu; Liying Xing; Zhi Du; Yuanmeng Tian; Li Jing; Han Yan; Min Lin; Boqiang Zhang; Shuang Liu; Yaping Pan; Chen Li Journal: Biomed Res Int Date: 2019-07-25 Impact factor: 3.411